T-cell lymphoma
Basic details
Preferred term: T-cell lymphoma
Alt. terms: T cell lymphoma | peripheral T-cell lymphoma | PTCL
HPO term: T-cell lymphoma
HPO code: HP:0012190
GenIA ID: 288
Last updated on: 2024-12-12 10:20:02
Cross ref. with other ontologies
NCIT: -
MESH: D016399
EFO: -
OAE: -
SNOMEDCT: -
ICD10: C84.4
Description
A type of lymphoma that originates in T-cells. Note: the term “peripheral” does not refer to the extremities, but identifies PTCL as a cancer that arises in the lymphoid tissues outside of the bone marrow such as lymph nodes, spleen, gastrointestinal tract, and skin.
Hierarchical classification
Reported patients added to GenIA DB
SubjectID | Sex | Fam.ID | Age* | Population | MatchedTerm | Diagnosis | Reference & Pub.codes |
---|---|---|---|---|---|---|---|
101023 | M | 210731 | 50 | German | Non-Hodgkin lymphoma | PMID:34975878 [Fam.F008:P008] | |
101076 | F | 210226 | 53 | German | Non-Hodgkin lymphoma | PMID:34975878 [Fam.F041:P041] | |
101088 | M | 211560 | 38 | German | Non-Hodgkin lymphoma | PMID:34975878 [Fam.F054:P054] | |
101133 | M | 210896 | 38 | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 13 | PMID:34975878 [Fam.F082:P082] | |
101160 | F | 211433 | - | Non-Hodgkin lymphoma | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34975878 [Fam.F101:P101] | |
101441 | M | 212174 | 19 | North American | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 8 | PMID:26206937 [P6] |
101808 | F | 211441 | - | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 2 | PMID:34975878 [Fam.F265:P265] | |
102222 | M | 214917 | 44 | German | Non-Hodgkin lymphoma | NFKB1 insufficiency | PMID:32278790 [BY.I.1]; PMID:35486341 [P074]; PMID:150198 [Fam.DJ:467]; PMID:36105815 [W295C] |
102229 | F | 214922![]() |
- | Anaplastic large-cell lymphoma | ARPC1B deficiency | PMID:32499645 [Fam.ARPC1B:II.1] | |
103929 | M | 215279 | 34 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K10:P12] |
103938 | M | 215285 | 17 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K16:P20] |
103946 | F | 215290 | 8 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K20:P25] |
103947 | F | 215291 | 21 | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22751495 [Fam.K21:P26] |
104357 | M | 215496 | - | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22084479 [P2] |
104361 | M | 215500 | - | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22084479 [P6] |
104365 | F | 215504 | - | French | Non-Hodgkin lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:22084479 [P10] |
104845 | F | 215579![]() |
35 | European | Non-Hodgkin lymphoma | NFKB1 insufficiency | PMID:32278790 [Fam.NZ:II.2(II.2)]; PMID:26279205 [Fam.NZ:II.2(II2)]; PMID:29403474 [Fam.NZ (5):II.2(II2)]; PMID:29806948 [Fam.NZ:II.2(II.2)]; PMID:30323807 [Fam.2:II.2(II.2)]; PMID:150198 [Fam.AC:II.2(109)] |
105173 | M | 215659 | - | Non-Hodgkin lymphoma | PMID:27102614 [Fam.A:I.1(father)] | ||
105280 | M | 215685![]() |
68 | European | Non-Hodgkin lymphoma | NFKB1 insufficiency | PMID:32278790 [Fam.B:I.1(I.1)]; PMID:29477724 [Fam.B:I.1(I:1)]; PMID:150198 [Fam.AV:I.1(242)] |
105338 | U | 215700 | 63 | European | T-cell lymphoma | NFKB1 insufficiency | PMID:32278790 [K.II.1]; PMID:29477724 [Fam.K:II.1(II:1)]; PMID:150198 [Fam.BE:280] |
105591 | F | 215821 | 16 | Caucasian | Non-Hodgkin lymphoma | Activated p110-delta syndrome 1 | PMID:24610295 [Fam.2:II.1(F2P2)] |
105910 | F | 215905 | 45 | Caucasian | Non-Hodgkin lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [K.II.1]; PMID:29729943 [Fam.K:II.1(K.II.1 (33))] |
106042 | M | 215927 | 22 | North American | Non-Hodgkin lymphoma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [FF.II.1]; PMID:29729943 [Fam.FF:II.1(FF.II.1 (77))] |
106164 | M | 215963 | - | Turkish | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 8 | PMID:31432443 [P8] |
106169 | F | 215968 | - | Turkish | Non-Hodgkin lymphoma | Immunodeficiency, common variable, 8 | PMID:31432443 [P13] |
107122 | U | 216341 | - | gamma-delta-T-cell derived lymphoma | NK/T-cell lymphomas 1 | PMID:25586472 [G618R] | |
107123 | U | 216342 | - | gamma-delta-T-cell derived lymphoma | NK/T-cell lymphomas 1 | PMID:25586472 [Y640F] | |
107134 | M | 216353 | - | Anaplastic large-cell lymphoma | NK/T-cell lymphomas 1 | PMID:23563237 [ALCL-1] | |
107135 | M | 216354 | - | Anaplastic large-cell lymphoma | NK/T-cell lymphomas 1 | PMID:23563237 [ALCL-2] | |
107136 | M | 216355 | - | T-cell lymphoma | NK/T-cell lymphomas 1 | PMID:23563237 [PTCL-1] | |
107137 | F | 216356 | - | T-cell lymphoma | NK/T-cell lymphomas 1 | PMID:23563237 [PTCL-2] |
*Age: age reported at the first known time of manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).